Archive for April, 2020

$SGLB is Cutting-Edge Provider of QC Software as Aviation Industry Begins Producing Parts with 3D Printing

April 2, 2020

  • New Boeing 777X aircraft recently took flight and showed further proof of market with many 3D printed parts
  • Sigma Labs is the leading provider of third party in-process quality-assurance software to commercial 3D metal printing industry
  • Sigma Labs with its patented PrintRite3D(R) software targets an untapped $2 billion market

History was made for the 3D printing industry recently with the first flight of the Boeing 777X aircraft, built using over 300 3D-printed parts – including an inducer never used in a commercial jet engine before 3D printing made it possible (http://nnw.fm/vbk7G). At the forefront of the 3D metal printing industry, Sigma Labs (NASDAQ: SGLB) is the sole provider of the requisite quality control software that’s removing scalability hurdles for the industry, enabling operators of machines to offset emerging quality problems in-process and boosting overall production and profitability.

“The inducer cannot be manufactured any other way, except by 3D printing,” said Zach Studt, senior manufacturing engineer at GE Aviation. “In this way, additive is unlocking performance of the engine.”

In addition to GE, 3D metal printing is also being driven forward by other large aviation-parts players such as Rolls-Royce, Airbus and Honeywell. Sigma Labs has test and evaluation programs in place with Airbus and several other leading aerospace manufacturers. Ever more companies are looking to leverage the additive manufacturing opportunity and the demand for innovative, time-saving solutions that refine the production process and provide cost effective quality control solutions. Sigma Labs provides the industry’s leading third party quality control software solution that addresses these critical issues – a requirement for the industry to move past the prototype phase into its full potential. Once impediments created by post-process, quality-control issues are removed, the industry looks set to grow by leaps and bounds.

Sigma Labs’ patented PrintRite3D(R) software addresses these issues in two ways: first, by enabling real-time, in-process detection of manufacturing irregularities, and then by providing error reporting that gives operators the critical, actionable information needed to address any developing anomalies found during the production process – potentially reducing rejected output and post-production inspection times.

Founded in 2010 by a team of Los Alamos National Labs scientists, Sigma Labs initially developed and licensed advanced metallurgical products for the military and dental industries. Following an assessment of 3D metal printing technology, the company concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities of the production process. The company’s patented and third-party validated software has achieved this objective, delivering crucial elements required to unleash the potential of 3D metal printing for the highly demanding and precision-dependent environments of the aerospace, defense, transportation, oil, gas, and biomedical industries.

SGLB is in an enviable position with a market projected to exceed $2 billion dollars, based on just the estimated number of 3D metal printers shipped between 2021 and 2027 (http://nnw.fm/2DJaR). What’s even more striking is that there are few known competitors for that $2 billion market (http://nnw.fm/7E8uN). Sigma Labs is leading this market space with technology unsurpassed by others in process quality control software for the metal additive manufacturing market. Beyond the huge existing market, 3D printing is booming, projected to grow at a CAGR of 32.5% from 2019 to 2024 (http://nnw.fm/V0gUY). With its unmatched in-process quality control software, Sigma should be able ride the crest of that wave as well.

With a robust patent strategy established to protect intellectual property, including seven patents granted, 18 pending, and four under application, SGLB is has become the premier provider of innovative software solutions to what is now being referred to as the fourth industrial revolution.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, April 2nd, 2020 Uncategorized Comments Off on $SGLB is Cutting-Edge Provider of QC Software as Aviation Industry Begins Producing Parts with 3D Printing

$MEDS Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit

April 1, 2020

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its wholly-owned subsidiary, Integra Pharma Solutions, has filed for an Emergency Use Authorization (“EUA”) with the U.S. Food and Drug Administration (“FDA”) in collaboration with its partnered manufacturer of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit. Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may, in an emergency, allow unapproved medical products or unapproved uses of approved medical products to be used in the diagnosis, treatment or prevention of serious or life-threatening diseases or when there are no adequate, approved, and available alternatives. The EAU filing has dual purposes; first serving as FDA notification that Trxade Group will be distributing the test and, secondly, if the EUA is approved, it enables Trxade Group to market the product for diagnostic use. Currently, the test is intended to aid in presenting a qualitative overview of antibody presence in patients who have possibly been infected by the Coronavirus (COVID-19).

To view the full press release, visit http://nnw.fm/ot1hM

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes Healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and Same Day or Mail Order Pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, April 1st, 2020 Uncategorized Comments Off on $MEDS Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit

$POAI Announces Financial Results for Full-Year 2019

April 1, 2020

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today released financial results for its full year ended December 31, 2019, as well as select corporate highlights. Among the highlights, the company reported its securing of a $15.0 million equity line with Oasis Capital, LLC, as well as its new subsidiary, Helomics, reaching milestone sequencing tumor cases in partnership with UPMC Magee. “2019 was not without its challenges for the entire healthcare technology industry, yet we continued to execute on our business model, making a synergistic acquisition and shoring up our balance sheet via a new $15.0 million equity line from Oasis Capital,” Predictive Oncology CFO Bob Myers said in the news release. “Our STREAMWAY line has maintained strong disposable product sales and we continue to sell the STREAMWAY System.”

To view the full press release, visit http://nnw.fm/8TLqd

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, April 1st, 2020 Uncategorized Comments Off on $POAI Announces Financial Results for Full-Year 2019

$ICLK Spotlighted in Publication Noting Huge Potential in China’s Digital Advertising Space

NEW YORK, April 01, 2020 — via NetworkWire — iClick Interactive Asia Group (NASDAQ:ICLK) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, “Digital Advertising and Enterprise SaaS Present Tremendous Opportunities as Online Marketing Soars in China”, visit: http://nnw.fm/93Hyy

Software adoption has been rising rapidly, especially in the advertising and marketing spaces, as both Chinese and foreign companies seek to effectively target and market towards Chinese customers, especially digitally where the captive Chinese consumers spend most of their time. With hundreds of millions of potential online customers and the growing wealth of businesses wanting to target them, huge potential exists in the Chinese digital advertising industry.

In this context, companies providing marketing and enterprise SaaS solutions are flourishing. One of the rising stars of the sector is iClick Interactive Asia Group (NASDAQ:ICLK). iClick is a proprietary, marketing-technology platform targeting Chinese consumers. The company’s data-driven analytical approach provides targeted advertising in a market that has historically been underserved but is increasingly online and accessible to such marketing.

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, our proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe. For more information, please visit ir.i-click.com.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within our InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit: https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Wednesday, April 1st, 2020 Uncategorized Comments Off on $ICLK Spotlighted in Publication Noting Huge Potential in China’s Digital Advertising Space

$GGBXF Allow Patients to Grow Their Own Medical Marijuana, N.J. Advocates Say

April 1, 2020

2020 has so far been anything but easy. The year began as the Coronavirus tore through Asia, and in three months it has spread to all continents except Antarctica, infected over 700,000 people worldwide and left at least 40,000 dead. Most of us have never seen anything like this, and experts say that the virus may affect up to 70% of the world’s population before it runs its course.

Naturally, state and national governments have taken steps to curb the spread of the virus. Since it is transmitted through droplets when an infected person coughs or sneezes, social distancing and self-isolation work best. People have been encouraged to stay indoors and only leave when they absolutely have to. All but the most essential businesses have also been ordered to shut down for the meantime as the world grapples with the pandemic.

However, several states have recognized that marijuana is essential, and have taken steps to ensure medical marijuana patients still get their medicine. These include online purchases, home deliveries and curbside pickups.

On Wednesday, the NJ Cannabis Insider hosted a webinar, and three of the state’s well-known cannabis industry leaders discussed the current situation and how to cater to medical marijuana patients. One of the ideas was allowing patients to grow their own medical marijuana, and how it would benefit them in these trying times.

The state’s original medical marijuana law has a provision letting patients grow up to six plants at home, but it was removed to improve the legislation’s chances at the ballot. Industry leaders say such a provision would now be a great help to medical marijuana patients.

“I talk to a lot of folks in the industry. A lot of people think that the industry is fighting this. I have not heard one credible source in the cannabis industry that is opposed,” says Bill Caruso, a founding member of New Jersey United for Marijuana Reform.

He states that the reservations elected officials have about home cultivation are valid due to the prospect of rogue growers feeding the black market with unregulated products. “But if we’re talking about allowing a patient to grow their own strain or something of that effect, I do think that there is an appetite for that.”

Jackie Cornell, Chief of Policy and Health Innovation for 1906, an edibles company, suggests that advocates needed to keep ‘the constant drumbeat of the patients’ needs and patients’ rights.’

“With everybody stuck at home, it’s a great opportunity for reaching out to your Senator, to your Assemblymember, to your mayor and your elected officials.”

It would be interesting to hear what industry players like Round Meadow Holdings Corp. and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) have to say about this tricky scenario of tweaking marijuana policy in a way that wasn’t included in the enabling law.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Wednesday, April 1st, 2020 Uncategorized Comments Off on $GGBXF Allow Patients to Grow Their Own Medical Marijuana, N.J. Advocates Say